- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Cyclacel Pharmaceuticals Inc
+ Add to WatchlistCYCC:US
2.9900 USD 0.0800 2.61%As of 20:10:00 ET on 05/22/2013.
Company Profile for Cyclacel Pharmaceuticals Inc (CYCC)
Cyclacel Pharmaceuticals Inc. discovers and develops small molecule cycle inhibitors for the treatment of cancer and other serious diseases.
Contact Information
Cyclacel Pharmaceuticals Inc
200 Connell Drive #1500
Berkeley Heights, NJ 07922
United States
Key Executives for Cyclacel Pharmaceuticals Inc (CYCC)
| Spiro G RombotisPresident/CEO | Paul McBarronExec VP:Finance/CFO/COO/Secy |
| Judy ChiaoVP:Clinical Dev & Reg Affairs |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page